Does late gadolinium enhancement predict cardiac events in patients with ischemic cardiomyopathy?

Despite improved clinical care and heightened public awareness, myocardial infarction (MI) and sudden cardiac death remain the leading causes of death in the United States.1 For this reason, clinical,2 laboratory,3 and electrocardiographic4 markers to identify those at risk for future cardiac events have been developed. In addition, both invasive (contrast angiography)5,6 and noninvasive (transthoracic echocardiography,7 radionuclide scintigraphy,8 magnetic resonance,9 and computer tomography10) imaging markers have been identified that further supplement the clinical markers to more accurately define cardiac risk. For the most part, these imaging markers rely on rest or stress measures of left ventricular (LV) ejection fraction,11 regional wall motion,12 myocardial perfusion,13 or the extent of coronary atherosclerosis.14 With the exception of coronary artery calcification scoring generated from computer tomography image datasets,15 there have been few new imaging markers (introduced during the past 15 years) that add incremental benefit to our ability to identify cardiac risk. Article p 2733 Late gadolinium enhancement (LGE) cardiac imaging was introduced by Saeed et al16 in 1989, to identify infarcted myocardial tissue during cardiovascular magnetic resonance (CMR). This technique incorporates the administration of relatively inert extracellular gadolinium contrast during gradient-echo inversion recovery imaging.17 On image acquisition, areas of noninfarcted tissue appear dark, and infarcted or fibrotic tissue appears bright because of reduced clearance and increased volume of distribution of the gadolinium.16 This fundamental aspect of delayed enhancement imaging has led to the recent expression, “bright is dead.” Combining the ability to characterize myocardial tissue with the heightened spatial resolution of CMR (voxel sizes are commonly acquired in the range of 1.5×1.5×6 mm), one can appreciate clear, crisp borders of infarct zones that are nearly identical to those observed histopathologically.18 In humans, the technique is reproducible, …

[1]  Roger B. Davis,et al.  Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.

[2]  L. Horowitz,et al.  Cellular Electrophysiology of Human Myocardial Infarction , 2005 .

[3]  A. Maseri,et al.  Comparison of Coronary Angiographic Findings in Acute and Chronic First Presentation of Ischemic Heart Disease , 1993, Circulation.

[4]  E. Antman,et al.  Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. , 1999, Circulation.

[5]  B. Zaret,et al.  Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. , 2000, Circulation.

[6]  D. Morrow Evidence-based decision limits for cardiac troponin: low-level elevation and prognosis. , 2004, American heart journal.

[7]  C. Higgins,et al.  Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP--enhanced MR imaging. , 1989, Radiology.

[8]  Robert R Edelman,et al.  Contrast-enhanced MR imaging of the heart: overview of the literature. , 2004, Radiology.

[9]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[10]  Daniel S Berman,et al.  Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers. , 2006, European heart journal.

[11]  P. Klootwijk,et al.  Acute coronary syndromes: diagnosis , 1999, The Lancet.

[12]  F. Knollmann,et al.  Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation. , 2000, Circulation.

[13]  S. Dymarkowski,et al.  Delayed contrast–enhanced MRI: use in myocardial viability assessment and other cardiac pathology , 2005, European radiology.

[14]  H. Smulyan,et al.  Ultrasonic Measurement of Left Ventricular Wall Motion in Acute Myocardial Infarction , 1971, Circulation.

[15]  D A Richards,et al.  Electrophysiologic substrate for ventricular tachycardia: correlation of properties in vivo and in vitro. , 1984, Circulation.

[16]  Olga Bondarenko,et al.  Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. , 2005, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[17]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[18]  G. Lowe Fibrinogen and cardiovascular disease: historical introduction. , 1995, European heart journal.

[19]  Bernd Hamm,et al.  Assessment of myocardial infarction in pigs using a rapid clearance blood pool contrast medium , 2004, Magnetic resonance in medicine.

[20]  R. Kim,et al.  Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function , 2001, Circulation.

[21]  C H Lorenz,et al.  Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.

[22]  W. Hundley,et al.  Magnetic Resonance Imaging Determination of Cardiac Prognosis , 2002, Circulation.

[23]  R. Passariello,et al.  Magnetic resonance imaging evaluation of myocardial perfusion. , 1998, The American journal of cardiology.

[24]  R. S. Cosby,et al.  Myocardial infarction; a re-evaluation of the diagnostic accuracy of the electrocardiogram. , 1950, The American journal of medicine.

[25]  L. Horowitz,et al.  Cellular electrophysiology of human myocardial infarction. 1. Abnormalities of cellular activation. , 1979, Circulation.

[26]  M. Cerqueira,et al.  Radionuclide assessment of infarct size and left ventricular function in clinical trials of thrombolysis. , 1991, Circulation.

[27]  Katherine C. Wu,et al.  Accuracy of Contrast-Enhanced Magnetic Resonance Imaging in Predicting Improvement of Regional Myocardial Function in Patients After Acute Myocardial Infarction , 2002, Circulation.

[28]  A. Pasquet,et al.  Relation of ultrasonic tissue characterization with integrated backscatter to contractile reserve in chronic left ventricular ischemic dysfunction. , 1998, The American journal of cardiology.

[29]  R. Kim,et al.  Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation , 2001, Circulation.

[30]  Wolfgang G Rehwald,et al.  Myocardial Magnetic Resonance Imaging Contrast Agent Concentrations After Reversible and Irreversible Ischemic Injury , 2002, Circulation.